lots of probabilities there, well thought out.
we have all waited a long time for a major approval; with trials my thoughts always go to how can MSB fast track results.. surely covid and ARD outomces are moving very fast with what the next new thing is, so to wait another 1.5 years with the way the FDA and trial readouts come to hand, is not really acceptable. dilution is an ugly process, so if other pay, for 3-4 end royaltity for paying for the trial seems fair investment for others.... 40 mil or so cost, will be had back with interest fairly quickly.. especially if linked to all ARDS
MSB 2022 - The road to commercialisation, page-327
-
- There are more pages in this discussion • 1,202 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.38 |
Change
0.000(0.00%) |
Mkt cap ! $1.569B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4932 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 1327 | 1 |
View Market Depth
| Last trade - 09.42am 17/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable